Table 1.
mRNAs | Expression in CLL |
Target | Function | Oncogenic or Suppressive | Refs. |
---|---|---|---|---|---|
miR-202-3p | Upregulated | Sufu gene |
‘suppressing fused’ (Sufu) is targeted by gene of miR-202-3p increase, modulator of the Gli Hedgehog signaling pathway -During development, it is thought to be involved in pattern formation and cellular proliferation. - decreasing in the intracellular level of this miRNA causes an increase in the expression level of Sufu, which aids tumor cell survival and progression. |
Oncogene | [69, 71] |
miR-146a/miR-451 | Upregulated | Kinases in Stromal cells | inducing the stromal cells activation by phosphorylation of several kinases | Oncogene | [69, 71, 75] |
miR-150 | Upregulated | c-Myb | playing an important role in the process of hematopoiesis, particularly in the development of lymphoid lineage | Oncogene | [69, 71] |
miR-19b | Upregulated | TP53 and MKI67 | TP53 downregulation and MKI67 upregulation as tumor cell proliferation, survival, and invasion mechanisms | Oncogene | [69, 76] |
miR-155 | Upregulated | SHIP1 | In CLL, it has an oncogenic role; it promotes the BCR response by targeting SHIP1. | Oncogene | [69, 71] |
miR-29 | Downregulated | TCL1 |
regulation of TCL1, MCL1 and DNA-methyltransferases |
Tumor suppressor function in aggressive CLLs (downregulated versus indolent CLL) |
[69, 71] |
miR-223 | Downregulated | HSPs | HSP90B1 | Oncogene | [69, 77, 78] |
Y RNA | Upregulated | it is overexpressed in tumors and is essential for cell proliferation | Oncogene | [69, 79] |